IT8122859A0 - Derivati dell'acido 2-idrossi-5-fenilazobenzoico, composizioni farmaceutiche che licontengono e procedimento per laloro preparazione. - Google Patents
Derivati dell'acido 2-idrossi-5-fenilazobenzoico, composizioni farmaceutiche che licontengono e procedimento per laloro preparazione.Info
- Publication number
- IT8122859A0 IT8122859A0 IT8122859A IT2285981A IT8122859A0 IT 8122859 A0 IT8122859 A0 IT 8122859A0 IT 8122859 A IT8122859 A IT 8122859A IT 2285981 A IT2285981 A IT 2285981A IT 8122859 A0 IT8122859 A0 IT 8122859A0
- Authority
- IT
- Italy
- Prior art keywords
- hydroxy
- derivatives
- procedure
- contain
- preparation
- Prior art date
Links
- JHDYSXXPQIFFJZ-UHFFFAOYSA-N chembl1834961 Chemical class C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC=CC=2)=C1 JHDYSXXPQIFFJZ-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B29/00—Monoazo dyes prepared by diazotising and coupling
- C09B29/10—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group
- C09B29/12—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group of the benzene series
- C09B29/14—Hydroxy carboxylic acids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8023826 | 1980-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8122859A0 true IT8122859A0 (it) | 1981-07-10 |
IT1138450B IT1138450B (it) | 1986-09-17 |
Family
ID=10514924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT22859/81A IT1138450B (it) | 1980-07-21 | 1981-07-10 | Derivati dell'acido 2-idrossi-5-fenilazobenzoico,composizioni farmaceutiche che li contengono e procedimento per la loro preparazione |
Country Status (8)
Country | Link |
---|---|
US (1) | US4412992A (it) |
JP (1) | JPS5753449A (it) |
DE (1) | DE3128819A1 (it) |
FR (1) | FR2493312A1 (it) |
HK (1) | HK31885A (it) |
IT (1) | IT1138450B (it) |
MY (1) | MY8600029A (it) |
SG (1) | SG6885G (it) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
WO1981002671A1 (en) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
DE3161862D1 (en) * | 1980-03-28 | 1984-02-16 | Ciba Geigy Ag | Azo dyestuffs, methods for their preparation and their use |
SE8405924L (sv) * | 1984-11-23 | 1986-05-24 | Pharmacia Ab | Nya azoforeningar |
US4975233A (en) * | 1988-12-09 | 1990-12-04 | Hoechst Celanese Corporation | Method of producing an enhanced polyester copolymer fiber |
US5064637A (en) * | 1989-05-30 | 1991-11-12 | Board Of Regents, The University Of Texas System | Substituted sulfonamide derivatives which inhibit allergic reactions |
JPH0586844U (ja) * | 1992-05-01 | 1993-11-22 | 株式会社柴崎製作所 | ピルファープルーフキャップ |
US5498608A (en) * | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
SE9700934D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | New formulation |
US6114382A (en) * | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
AU2001285489A1 (en) | 2000-08-29 | 2002-03-13 | Nobex Corporation | 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
WO2002018324A2 (en) | 2000-08-29 | 2002-03-07 | Nobex Corporation | Immunoregulatory compounds, derivatives thereof and their use |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
WO2005094448A2 (en) * | 2004-03-23 | 2005-10-13 | Nobex Corporation | Methods and compositions employing 4-aminophenylacetic acid compounds |
US20070213304A1 (en) | 2004-02-06 | 2007-09-13 | Thomas Borody | Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome |
JP5009152B2 (ja) * | 2004-05-28 | 2012-08-22 | サリックス ファーマシューティカルズ, インコーポレイテッド | 放射線誘発性腸炎の予防、処置、および回復 |
WO2006014549A2 (en) | 2004-07-07 | 2006-02-09 | Nobex Corporation | Synthesis of azo bonded immunoregulatory compounds |
US7741359B2 (en) * | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
WO2006125293A1 (en) * | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
US7498355B2 (en) | 2005-05-27 | 2009-03-03 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
US8921344B2 (en) | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
NZ565974A (en) * | 2005-08-24 | 2012-07-27 | Salix Pharmaceuticals Ltd | Balsalazide formulations and manufacture and use thereof |
US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
CA2653869A1 (en) * | 2006-06-06 | 2007-12-13 | Antibe Therapeutics Inc. | Salts of trimebutine and n-desmethyl trimebutine |
US7271253B1 (en) | 2006-08-10 | 2007-09-18 | Apotex Pharmachem Inc. | Safe process for the preparation of balsalazide |
AU2008347024A1 (en) | 2007-10-19 | 2009-07-16 | Omm Scientific, Inc. | Methods of inhibiting bacterial virulence and compounds relating thereto |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
CN102627624B (zh) * | 2012-04-25 | 2014-03-19 | 西南大学 | 4-(4-氨基苯磺酰胺基)苯乙酸衍生物及其制备方法和应用 |
WO2013167990A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of depression |
SG11201407303SA (en) | 2012-05-07 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
EP2847169A4 (en) | 2012-05-07 | 2015-09-30 | Cellix Bio Private Ltd | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
WO2013168025A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of blood clotting disorders |
WO2013167992A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9403857B2 (en) | 2012-05-10 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
WO2013168012A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
CA2873096A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
AU2013264896A1 (en) | 2012-05-23 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
WO2013175377A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
EP3004049B1 (en) | 2013-06-04 | 2018-09-05 | Cellixbio Private Limited | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CN104974061B (zh) * | 2014-04-14 | 2017-11-14 | 辽宁省药物研究院 | 一种巴柳氮钠的制备方法 |
CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
EP3201168B1 (en) | 2014-09-29 | 2020-03-18 | Cellix Bio Private Limited | Compounds and compositions for the treatment of multiple sclerosis |
CA2965449C (en) | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
CN107428697A (zh) | 2015-01-06 | 2017-12-01 | 塞尔利克斯生物私人有限公司 | 用于治疗炎症和疼痛的组合物和方法 |
CN110003044A (zh) * | 2019-04-26 | 2019-07-12 | 赤峰蒙欣药业有限公司 | 一种巴柳氮钠的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4045429A (en) * | 1970-03-06 | 1977-08-30 | Pharmacia Aktiebolag | 4-(4-Hydroxy- or acetoxy-3-carbomethoxyphenylazo)-benzenesulphonyl chloride |
SE353537B (it) * | 1970-03-06 | 1973-02-05 | Pharmacia Ab | |
BE791889A (fr) * | 1971-11-26 | 1973-05-24 | Pharmacia Ab | Nouveaux derives de la pyridine |
FR2212391B1 (it) * | 1972-12-28 | 1976-06-04 | Ugine Kuhlmann |
-
1981
- 1981-07-08 US US06/281,504 patent/US4412992A/en not_active Expired - Lifetime
- 1981-07-10 IT IT22859/81A patent/IT1138450B/it active Protection Beyond IP Right Term
- 1981-07-16 JP JP56111534A patent/JPS5753449A/ja active Granted
- 1981-07-21 DE DE19813128819 patent/DE3128819A1/de active Granted
- 1981-07-21 FR FR8114505A patent/FR2493312A1/fr active Granted
-
1985
- 1985-01-26 SG SG68/85A patent/SG6885G/en unknown
- 1985-04-25 HK HK318/85A patent/HK31885A/xx not_active IP Right Cessation
-
1986
- 1986-12-30 MY MY29/86A patent/MY8600029A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US4412992A (en) | 1983-11-01 |
MY8600029A (en) | 1986-12-31 |
JPS5753449A (en) | 1982-03-30 |
FR2493312B1 (it) | 1984-09-21 |
FR2493312A1 (fr) | 1982-05-07 |
DE3128819A1 (de) | 1982-04-15 |
SG6885G (en) | 1985-06-14 |
DE3128819C2 (it) | 1990-02-15 |
IT1138450B (it) | 1986-09-17 |
JPS6225656B2 (it) | 1987-06-04 |
HK31885A (en) | 1985-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8122859A0 (it) | Derivati dell'acido 2-idrossi-5-fenilazobenzoico, composizioni farmaceutiche che licontengono e procedimento per laloro preparazione. | |
IT1168168B (it) | Procedimento per la preparazione di derivati dell'acido chinolin-carbossilico | |
IT8019992A0 (it) | Derivati dell'acido 3-fosfonocefalosporanico, procedimenti per la loro preparazione e composizione farmaceutica che li comprende. | |
IT7927748A0 (it) | Derivati dell'acido 6,6'-diapopsi psicarotenedioico e relativi procedimenti di preparazione. | |
IT7948011A0 (it) | Procedimento per la preparazione di derivati di 2-fenilimminoimidazolidine composizioni farmaceutiche che li contengono e prodotto ottenuto | |
IT7922947A0 (it) | Derivati di diammidi dell'acido cicloesen-1,2-bicarbossilico e composizioni erbicide che licontengono. | |
IT8322648A0 (it) | Derivati dell'acido 4-fenil4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali. | |
IT7927962A0 (it) | Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico. | |
IT8023601A0 (it) | Derivati ammidici dell'acido p-isobutilfenilpropionico, procedimento per la loro preparazione e relative composizioni farmaceutici. | |
IT1221914B (it) | Derivati dell'acido carbazico,procedimento per la loro preparazione e composizioni che ne contengono | |
IT1183053B (it) | Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono | |
IT8024152A0 (it) | Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti | |
IT8103423A0 (it) | Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono | |
IT8621135A0 (it) | Derivati dell'acito cef-3-em-4-carbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT1168089B (it) | Procedimento per la preparazione di derivati dell'acido penem-3-carbossilico | |
IT8222500A0 (it) | Derivati dell'acido 7 bet5a-amino-3-metossi-3-cefem-4-carbossilico,procedimenti per la loro preparazione e composizioni farmaceutiche che licontengono. | |
IT8223332A0 (it) | Derivati dell'acido lattobionico, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono. | |
IT8422646A0 (it) | Contengono. composti derivati dell'acido beta-ossimino-propionico adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li | |
IT8420315A0 (it) | Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico, procedimento di preparazione e composizioni farmaceutiche che licontengono. | |
IT8249331A0 (it) | Derivati monosostituiti dell'acido 4-fenil 4-osso buten-2-cico, utili come medicamenti, e le composizioni che li contengono | |
IT8222854A0 (it) | Derivati dell'acido lattobionico, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono. | |
IT8222843A0 (it) | Derivati dell'acido 5-tiazolil-acetico, procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati. | |
IT8420802A0 (it) | Derivati dell'acido alfa-metil-4-(2-tienilcarbonil)benzeneacetico, loro preparazione e composizioni farmaceutiche che licontengono. | |
IT8222495A0 (it) | Derivati dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT8021053A0 (it) | Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MEDD | Supplementary protection certificate for pharmaceutical products: granted |
Free format text: CCP 660, 19990524; BIOREX LABORATORIES LIMITED |
|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960730 |